Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pGz in Primary Mitochondrial Disorders
NCT05569122Phase 1Recruiting
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Mar 2023
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (3 arms), sponsored by Children's Hospital of Philadelphia. Primary endpoints: Maximal Oxygen Consumption at 1 hour, Arterial-Venous Oxygen Difference and 1 more. Started Mar 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05569122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05569122.